K-RAS and P53 Mutations in Association with COX-2 and Htert Expression and Clinico-Pathological Status of Nsclc Patients

We evaluated the occurrence of mutations in P53, K-RAS, COX-2, expression of COX-2 and hTERT and relations among clinicopathological signs. P53 mutations were identified in 34.4% of tumours, the majority of them occurring in SCC (squamous cell carcinoma, 55.6%). K-RAS was mutated in 12.2% of NSCLC t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stražišar, Mojca, Rott, Tomaž, Glavač, Damjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2008
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827803/
https://www.ncbi.nlm.nih.gov/pubmed/18957720
http://dx.doi.org/10.1155/2008/232743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827803/
https://www.ncbi.nlm.nih.gov/pubmed/18957720
http://dx.doi.org/10.1155/2008/232743

Ejemplares similares